Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George J Netto

Showing results (141-150 of 315) with videos related to

Pageof 32
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2012
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancerAlcides Chaux, Sarah B Peskoe, Nilda Gonzalez-Roibon, et al.
BJU International|October 13, 2015
Extent of renal vein invasion influences prognosis in patients with renal cell carcinomaMark W Ball, Michael A Gorin, Kelly T Harris, et al.
Human Pathology|October 19, 2015
Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinomaYasemin Ozluk, Diana Taheri, Andres Matoso, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Human Pathology|April 13, 2016
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsGunes Guner, Justin A Bishop, Stephania M Bezerra, et al.
Journal of Hematology & Oncology|July 22, 2014
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other originsXiaoyong Zheng, Jian Zhuge, Stephania M Bezerra, et al.
Human Pathology|November 2, 2015
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladderLeonardo O Reis, Diana Taheri, Alcides Chaux, et al.
The Prostate|February 10, 2023
Identification of androgen response-related lncRNAs in prostate cancerSanthosh Kumar Karthikeyan, Nuo Xu, James E Ferguson Rd, et al.
Virchows Archiv : an International Journal of Pathology|July 14, 2019
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladderMaria Del Carmen Rodriguez Pena, Alcides Chaux, Marie-Lisa Eich, et al.
Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
Pageof 32

Showing results (141-150 of 315) with videos related to

Sort By:
Pageof 32
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 12, 2012
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancerAlcides Chaux, Sarah B Peskoe, Nilda Gonzalez-Roibon, et al.
BJU International|October 13, 2015
Extent of renal vein invasion influences prognosis in patients with renal cell carcinomaMark W Ball, Michael A Gorin, Kelly T Harris, et al.
Human Pathology|October 19, 2015
Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinomaYasemin Ozluk, Diana Taheri, Andres Matoso, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 19, 2020
TFEB rearranged renal cell carcinoma. A clinicopathologic and molecular study of 13 cases. Tumors harboring MALAT1-TFEB, ACTB-TFEB, and the novel NEAT1-TFEB translocations constantly express PDL1Anna Caliò, Shuko Harada, Matteo Brunelli, et al.
Human Pathology|April 13, 2016
The utility of STAT6 and ALDH1 expression in the differential diagnosis of solitary fibrous tumor versus prostate-specific stromal neoplasmsGunes Guner, Justin A Bishop, Stephania M Bezerra, et al.
Journal of Hematology & Oncology|July 22, 2014
High frequency of TERT promoter mutation in small cell carcinoma of bladder, but not in small cell carcinoma of other originsXiaoyong Zheng, Jian Zhuge, Stephania M Bezerra, et al.
Human Pathology|November 2, 2015
Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladderLeonardo O Reis, Diana Taheri, Alcides Chaux, et al.
The Prostate|February 10, 2023
Identification of androgen response-related lncRNAs in prostate cancerSanthosh Kumar Karthikeyan, Nuo Xu, James E Ferguson Rd, et al.
Virchows Archiv : an International Journal of Pathology|July 14, 2019
Immunohistochemical assessment of basal and luminal markers in non-muscle invasive urothelial carcinoma of bladderMaria Del Carmen Rodriguez Pena, Alcides Chaux, Marie-Lisa Eich, et al.
Human Pathology|May 22, 2012
GATA binding protein 3 is down-regulated in bladder cancer yet strong expression is an independent predictor of poor prognosis in invasive tumorHiroshi Miyamoto, Koji Izumi, Jorge L Yao, et al.
Pageof 32